Tuesday 29 September 2015 7:23 am Roche breast cancer drug wins approval for use in UK By: Sarah Spickernell Add as a preferred source on Google NULL
Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma Business Wire
Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument Business Wire